Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Dev Neuropsychol ; 36(4): 473-92, 2011.
Article in English | MEDLINE | ID: mdl-21516544

ABSTRACT

Hormonal imbalances during development may have long-lasting effects. Using functional magnetic resonance imaging (fMRI), we compared 14 youths with Congenital Adrenal Hyperplasia (CAH), a genetic disorder of hormonal dysfunction, with 22 healthy controls on memory encoding of emotional faces. Patients remembered fewer faces than controls, particularly fearful faces. FMRI data to successfully encoded fearful faces revealed that males with CAH showed significant activations in amygdala, hippocampus, and anterior cingulate relative to unaffected males, while females with CAH demonstrated deactivations relative to unaffected females in these regions. Findings indicate that steroid abnormalities during development can have important effects on neural correlates of emotional memory.


Subject(s)
Adrenal Hyperplasia, Congenital , Brain/blood supply , Emotions/physiology , Memory/physiology , Steroids/metabolism , Adolescent , Adrenal Hyperplasia, Congenital/complications , Adrenal Hyperplasia, Congenital/metabolism , Adrenal Hyperplasia, Congenital/pathology , Brain/pathology , Brain Mapping , Child , Female , Humans , Image Processing, Computer-Assisted , Intelligence , Magnetic Resonance Imaging/methods , Male , Oxygen/blood , Photic Stimulation/methods , Reaction Time/physiology , Statistics as Topic
2.
Int J Neuropsychopharmacol ; 14(4): 445-57, 2011 May.
Article in English | MEDLINE | ID: mdl-20860880

ABSTRACT

Major questions remain about how sex hormones influence human brain development and cognition. Studies in humans and animals suggest a strong impact of androgen on the structure and function of the medial temporal lobe (MTL) and striatum. Using voxel-based morphometry (DARTEL), we compared MTL and striatal structures in 13 [mean age (±S.D.) 12.7±3.2 yr, mean bone age 14.8±3.2 yr] boys with familial male precocious puberty (FMPP), characterized by early excess androgen secretion, and 39 healthy age-matched boys (mean age 14.3±2.5 yr). The FMPP group showed significantly larger grey-matter volume (GMV) in parahippocampal and fusiform gyri as well as putamen relative to controls. By comparison, larger GMV for controls relative to patients was only apparent in the precentral gyrus. Exploratory regression analyses that examined the impact of age on the current findings revealed a significant increase of GMV in the putamen with age in patients suffering from excess androgen but not in controls. Finally, current levels of free testosterone were obtained in the patient group. Analyses revealed a significant negative association indicating that FMPP boys with low levels of bioavailable testosterone exhibited high GMV in the bilateral striatum. The findings suggest a critical influence of androgen on human brain development and are discussed in relation to male-dominant psychiatric childhood disorders.


Subject(s)
Androgens/physiology , Corpus Striatum/pathology , Puberty, Precocious/pathology , Temporal Lobe/pathology , Testosterone/physiology , Adolescent , Age Factors , Androgen Antagonists/therapeutic use , Aromatase Inhibitors/therapeutic use , Attention Deficit Disorder with Hyperactivity/complications , Child , Humans , Male , Psychiatric Status Rating Scales , Puberty, Precocious/complications , Puberty, Precocious/drug therapy , Puberty, Precocious/physiopathology , Spironolactone/therapeutic use , Temporal Lobe/physiopathology , Testolactone/therapeutic use , Testosterone/blood
3.
Eur J Endocrinol ; 163(5): 801-10, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20807778

ABSTRACT

OBJECTIVE: Very little is known about the mental health status in children with genetic causes of hyperandrogenism. This study sought to characterize psychiatric morbidity in this group. DESIGN/METHODS: Children (8-18 years) with the diagnosis of classic congenital adrenal hyperplasia (CAH) or familial male precocious puberty (FMPP) underwent a semi-structured psychiatric interview, the Kiddie Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version. According to sex and the literature, incidence of identified psychopathology was compared between the two endocrinological groups. We evaluated 72 patients: 54 CAH (21 females) and 18 FMPP. RESULTS: Twenty-four (44.4%) CAH patients and 10 (55.6%) FMPP patients met the criteria for at least one lifetime psychiatric diagnosis. Attention-deficit hyperactivity disorder (ADHD) was present in 18.2% of CAH males, 44.4% of FMPP males, and one case (4.8%) in CAH females. A high rate of anxiety disorders was also found in all the three groups (17-21%). Relative to females with CAH, the FMPP patients exhibited higher rates of ADHD. Age at diagnosis and the treatment modalities were not associated with psychopathology. Rates of psychiatric disorder, specifically ADHD and anxiety disorders, were higher than in the general population. CONCLUSION: Although anxiety disorders may occur at an increased rate in children with chronic illness, androgens may contribute to higher risk for psychopathology in pediatric patients with genetic cause of excess androgen. Early diagnosis and treatment of childhood hyperandrogenism is essential for optimal development. The results suggest that assessment for psychiatric disorders should be part of the routine evaluation of these patients.


Subject(s)
Hyperandrogenism/genetics , Hyperandrogenism/psychology , Mental Disorders/genetics , Mental Disorders/psychology , Adolescent , Adrenal Hyperplasia, Congenital/diagnosis , Adrenal Hyperplasia, Congenital/genetics , Adrenal Hyperplasia, Congenital/psychology , Anxiety/diagnosis , Anxiety/genetics , Anxiety/psychology , Attention Deficit Disorder with Hyperactivity/diagnosis , Attention Deficit Disorder with Hyperactivity/genetics , Attention Deficit Disorder with Hyperactivity/psychology , Child , Female , Humans , Hyperandrogenism/complications , Hyperandrogenism/diagnosis , Male , Mental Disorders/diagnosis , Puberty, Precocious/diagnosis , Puberty, Precocious/genetics , Puberty, Precocious/psychology
4.
Int J Pediatr Endocrinol ; 2010: 275213, 2010.
Article in English | MEDLINE | ID: mdl-21274448

ABSTRACT

Patients with rare and complex diseases such as congenital adrenal hyperplasia (CAH) often receive fragmented and inadequate care unless efforts are coordinated among providers. Translating the concepts of the medical home and comprehensive health care for individuals with CAH offers many benefits for the affected individuals and their families. This manuscript represents the recommendations of a 1.5 day meeting held in September 2009 to discuss the ideal goals for comprehensive care centers for newborns, infants, children, adolescents, and adults with CAH. Participants included pediatric endocrinologists, internal medicine and reproductive endocrinologists, pediatric urologists, pediatric surgeons, psychologists, and pediatric endocrine nurse educators. One unique aspect of this meeting was the active participation of individuals personally affected by CAH as patients or parents of patients. Representatives of Health Research and Services Administration (HRSA), New York-Mid-Atlantic Consortium for Genetics and Newborn Screening Services (NYMAC), and National Newborn Screening and Genetics Resource Center (NNSGRC) also participated. Thus, this document should serve as a "roadmap" for the development phases of comprehensive care centers (CCC) for individuals and families affected by CAH.

5.
Clin Endocrinol (Oxf) ; 72(4): 441-7, 2010 Apr.
Article in English | MEDLINE | ID: mdl-19486026

ABSTRACT

OBJECTIVE: Existing glucocorticoid treatment for congenital adrenal hyperplasia (CAH) is suboptimal and nonphysiological. We compared hormonal profiles during therapy with a new modified-release hydrocortisone (MR-HC), Chronocort, to conventional hydrocortisone (HC), Cortef, in patients with CAH. DESIGN AND PATIENTS: We conducted a Phase 2, open-label, crossover pharmacokinetic and pharmacodynamic study in 14 patients (out of whom seven were male subjects, age ranging from 17 to 55) with classic 21-hydroxylase deficiency. One week of thrice daily HC (10, 5 and 15 mg) was followed by 1 month of once daily MR-HC (30 mg at 22:00 hours). Twenty four-hour sampling of cortisol, 17-hydroxyprogesterone (17-OHP), androstenedione, and ACTH was performed at steady state. MEASUREMENTS: The primary outcome measures were 8- and 24-h area under the curve (AUC) hormones and 08:00 hours 17-OHP. RESULTS: Hydrocortisone therapy resulted in three cortisol peaks. A single cortisol peak occurred at approximately 06:00 hours on MR-HC. MR-HC resulted in significantly (P < 0.001) lower 24-h afternoon (12:00 to 20:00 hours), and night-time (20:00 to 04:00 hours) cortisol as compared with HC. From 04:00 to 12:00 hours, when physiological cortisol is highest, cortisol was higher on MR-HC than HC (P < 0.001). Patients on MR-HC had significantly (P < 0.05) higher afternoon (12:00 to 20:00 hours) 17-OHP, androstenedione and ACTH, but significantly (P = 0.025) lower 08:00 hours 17-OHP. No serious adverse events occurred. CONCLUSIONS: Modified-release hydrocortisone represents a promising new treatment for CAH. Overnight adrenal androgens were well-controlled, but rose in the afternoon with once-daily dosing suggesting that a morning dose of glucocorticoid is needed. Further studies are needed to determine the optimal dosing regimen and long-term clinical outcome.


Subject(s)
Adrenal Hyperplasia, Congenital/drug therapy , Hydrocortisone/administration & dosage , Adolescent , Adult , Area Under Curve , Circadian Rhythm , Cross-Over Studies , Delayed-Action Preparations/pharmacokinetics , Delayed-Action Preparations/therapeutic use , Drug Administration Schedule , Female , Humans , Hydrocortisone/pharmacokinetics , Male , Middle Aged
6.
Am J Med Genet A ; 149A(12): 2803-8, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19921645

ABSTRACT

Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is an autosomal recessive disorder and is the most common cause of ambiguous genitalia in the newborn. The genes encoding 21-hydroxylase, CYP21A2, and tenascin-X (TNX), TNXB, are located within the HLA complex, in a region of high gene density termed the RCCX module. The module has multiple pseudogenes as well as tandem repeat sequences that promote misalignment during meiosis leading to complex gene rearrangements, deletions and gene conversion events. CYP21A2 mutations cause CAH, and TNX deficiency has been identified as a cause of hypermobility type Ehlers-Danlos syndrome (EDS). Here we report on a three-generation family with a heterozygous deletion encompassing CYP21A2 and TNXB that initially came to medical attention due to the diagnosis of CAH in the proposita. Southern blotting and PCR-based analysis of the RCCX module revealed a CYP21A2 deletion extending into TNXB in one allele and a CYP21A2 point mutation in the other allele. Family history is notable for joint hypermobility. Additional radiological and clinical investigations showed a quadricuspid aortic valve, single kidney, bicornuate uterus and a bifid uvula in the proposita, and mitral valve prolapse in her mother. These findings further delineate the phenotype of the CAH-TNX contiguous gene deletion syndrome and point to an intersection of connective tissue dysplasias with a common gene-mediated endocrine disorder.


Subject(s)
Aortic Valve/abnormalities , Gene Deletion , Heart Valve Diseases/genetics , Steroid 21-Hydroxylase/genetics , Tenascin/genetics , Adult , Blotting, Southern , Child , Female , Genome, Human/genetics , Haplotypes/genetics , Heart Valve Diseases/diagnostic imaging , Humans , Infant, Newborn , Magnetic Resonance Imaging , Male , Pedigree , Phenotype , Polymerase Chain Reaction , Ultrasonography
7.
J Clin Endocrinol Metab ; 92(8): 3019-24, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17535996

ABSTRACT

CONTEXT: Patients with classic congenital adrenal hyperplasia (CAH) have adrenomedullary dysplasia and hypofunction, and their lack of adrenomedullary reserve has been associated with a defective glucose response to brief high-intensity exercise. OBJECTIVE: Our objective was to assess hormonal, metabolic, and cardiovascular response to prolonged moderate-intensity exercise comparable to brisk walking in adolescents with classic CAH. SUBJECTS AND METHODS: We compared six adolescents with classic CAH (16-20 yr old) with seven age-, sex-, and body mass index group-matched controls (16-23 yr old) using a 90-min standardized ergometer test. Metabolic, hormonal, and cardiovascular parameters were studied during exercise and recovery. RESULTS: Glucose did not change throughout exercise and recovery for controls, whereas CAH patients showed a steady decline in glucose during exercise with an increase in glucose in the postexercise period. Glucose levels were significantly lower in CAH patients at 60 (P = 0.04), 75 (P = 0.01), and 90 (P = 0.03) min of exercise and 15 (P = 0.02) min post exercise, whereas glucose levels were comparable between the two groups early in exercise and at 30 min (P = 0.19) post exercise. As compared with controls, CAH patients had significantly lower epinephrine (P = 0.002) and cortisol (P < or = 0.001) levels throughout the study and similar norepinephrine, glucagon, and GH levels. Patients with CAH and controls had comparable cardiovascular parameters and perceived level of exertion. Despite having lower glucose levels, insulin levels were slightly higher in CAH patients during the testing period (P = 0.17), suggesting insulin insensitivity. CONCLUSION: CAH patients have defective glycemic control and altered metabolic and hormonal responses during prolonged moderate-intensity exercise comparable to brisk walking.


Subject(s)
Adrenal Hyperplasia, Congenital/metabolism , Blood Glucose/metabolism , Epinephrine/metabolism , Exercise/physiology , Adolescent , Adrenocorticotropic Hormone/blood , Adult , Blood Pressure/physiology , Body Mass Index , Chromatography, High Pressure Liquid , Electrochemistry , Epinephrine/blood , Exercise Test , Female , Glucagon/blood , Heart Rate/physiology , Human Growth Hormone/blood , Humans , Hydrocortisone/blood , Insulin/blood , Luminescence , Male , Norepinephrine/blood , Puberty/physiology , Walking/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...